Stemmatters is a Portuguese contract development and manufacturing organization operating in therapeutic products based on cells, tissues and blood derivatives.

Created as a spin-off of the academy (University of Minho, Portugal), Stemmatters has more than a decade of experience in developing our own assets and those of our external partners.

Stemmatters provides bespoke products, processes and analytical development services tailored to each client’s needs. They have a strong track record of continuous technology transfer procedures, ensuring the ability to implement and internally validate optimized manufacturing solutions. Stemmatters’ track record is demonstrated by successful audits at multiple business partner locations and authorizations from competent authorities.

Stemmatters’ innovation offering is underpinned by an innovative biomaterials product platform that supports the formulation of combination products for multiple indications (see mimsys®platform).